1059626-05-9 Usage
General Description
(4-Fluorobenzyl)hydrazine hydrochloride is a chemical compound that consists of a hydrazine derivative with a 4-fluorobenzyl group attached. It is typically used in organic synthesis and chemical research as a reagent for the preparation of various pharmaceutical intermediates and other organic compounds. The hydrochloride salt form of this compound allows for easier handling and storage due to its increased stability and reduced reactivity. (4-Fluorobenzyl)hydrazine hydrochloride has potential applications in the development of new drugs and other bioactive molecules due to its unique chemical properties and reactivity. However, it is important to handle this chemical with care and utilize proper safety precautions due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 1059626-05-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,9,6,2 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1059626-05:
(9*1)+(8*0)+(7*5)+(6*9)+(5*6)+(4*2)+(3*6)+(2*0)+(1*5)=159
159 % 10 = 9
So 1059626-05-9 is a valid CAS Registry Number.
1059626-05-9Relevant articles and documents
Design, synthesis and antiviral activity of novel pyridazines
Wang, Ziwen,Wang, Mingxiao,Yao, Xue,Li, Yue,Tan, Juan,Wang, Lizhong,Qiao, Wentao,Geng, Yunqi,Liu, Yuxiu,Wang, Qingmin
experimental part, p. 33 - 41 (2012/09/08)
A series of pyridazines were prepared and evaluated for their anti-HIV activity. The new synthetic route involving a novel rearrangement reaction provided a practical method for the preparation of 5-hydroxypyridazines. The primary bioassay results indicated that most of the pyridazines possess anti-HIV activity. It ought to been mentioned that the rearranged compounds 35 and 39 exhibited relatively higher HIV inhibitory effect. Most of the synthesized compounds were also found to possess good anti-TMV activity, of which compound 9 showed similar in vivo anti-TMV activity to commercial plant virucide Ribavirin. This work provides a new and efficient approach to evolve novel multi-functional antiviral agents by rational integration and optimization of previously reported antiviral agents.
